Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001181431-09-035412
Filing Date
2009-07-15
Accepted
2009-07-15 14:56:31
Documents
1
Effectiveness Date
2009-07-15
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10655
  Complete submission text file 0001181431-09-035412.txt   12277
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-109193 | Film No.: 09945813
SIC: 2834 Pharmaceutical Preparations